martes, 23 de julio de 2013

Drug Informatio​n Update - CORRECTION - FDA Webinar: Webinar Draft GFI on Human Immunodefi​ciency Virus-1 Infection: Developing Antiretrov​iral Drugs for Treatment; Availabili​ty - July 25, 2013

FDA Division of Drug Information: Know the Moment It Happens
The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.

On July 25, 2013, from 2:00PM-3:00PM (EDT), FDA will present a webinar on a new draft guidance entitled "Draft Guidance for Industry on Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment; Availability."
The webinar will provide an opportunity to learn about the guidance from individuals involved in its preparation. It is also intended to encourage the submission of questions or comments while the guidance is still in draft form.
Questions may be submitted online during the webinar and will be addressed as time permits. All questions should also be submitted to docket so that they can be formally processed by FDA.

No hay comentarios:

Publicar un comentario